| 000 | 00953 a2200265 4500 | ||
|---|---|---|---|
| 005 | 20250516124529.0 | ||
| 264 | 0 | _c20121226 | |
| 008 | 201212s 0 0 eng d | ||
| 022 | _a1533-4406 | ||
| 024 | 7 |
_a10.1056/NEJMc1212744 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aKern, David G | |
| 245 | 0 | 0 |
_aHow physicians interpret research funding disclosures. _h[electronic resource] |
| 260 |
_bThe New England journal of medicine _c12 2012 |
||
| 300 |
_a2359; author reply 2360 p. _bdigital |
||
| 500 | _aPublication Type: Letter; Comment | ||
| 650 | 0 | 4 |
_aDrug Evaluation _xstandards |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aResearch Design _xstandards |
| 650 | 0 | 4 | _aResearch Support as Topic |
| 700 | 1 | _aBlumsohn, Aubrey | |
| 700 | 1 | _aPoses, Roy M | |
| 773 | 0 |
_tThe New England journal of medicine _gvol. 367 _gno. 24 _gp. 2359; author reply 2360 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1056/NEJMc1212744 _zAvailable from publisher's website |
| 999 |
_c22341216 _d22341216 |
||